India · Delayed Price · Currency is INR NSE:HCG Statistics
Total Valuation
NSE:HCG has a market cap or net worth of INR 85.23 billion. The enterprise value is 100.90 billion.
| Market Cap | 85.23B |
| Enterprise Value | 100.90B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:HCG has 149.30 million shares outstanding. The number of shares has increased by 3.40% in one year.
| Current Share Class | 149.30M |
| Shares Outstanding | 149.30M |
| Shares Change (YoY) | +3.40% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 9.41% |
| Owned by Institutions (%) | 18.58% |
| Float | 59.34M |
Valuation Ratios
The trailing PE ratio is 744.13 and the forward PE ratio is 43.07. NSE:HCG's PEG ratio is 0.51.
| PE Ratio | 744.13 |
| Forward PE | 43.07 |
| PS Ratio | 3.14 |
| PB Ratio | 5.94 |
| P/TBV Ratio | 9.12 |
| P/FCF Ratio | 285.45 |
| P/OCF Ratio | 28.98 |
| PEG Ratio | 0.51 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.47, with an EV/FCF ratio of 337.95.
| EV / Earnings | 893.36 |
| EV / Sales | 3.72 |
| EV / EBITDA | 20.47 |
| EV / EBIT | 42.54 |
| EV / FCF | 337.95 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 1.12.
| Current Ratio | 0.91 |
| Quick Ratio | 0.70 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 3.28 |
| Debt / FCF | 53.90 |
| Interest Coverage | 1.51 |
Financial Efficiency
Return on equity (ROE) is 1.80% and return on invested capital (ROIC) is 4.80%.
| Return on Equity (ROE) | 1.80% |
| Return on Assets (ROA) | 4.01% |
| Return on Invested Capital (ROIC) | 4.80% |
| Return on Capital Employed (ROCE) | 8.21% |
| Weighted Average Cost of Capital (WACC) | 4.86% |
| Revenue Per Employee | 4.01M |
| Profits Per Employee | 16,706 |
| Employee Count | 6,761 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 20.52 |
Taxes
In the past 12 months, NSE:HCG has paid 168.47 million in taxes.
| Income Tax | 168.47M |
| Effective Tax Rate | 43.54% |
Stock Price Statistics
The stock price has decreased by -23.27% in the last 52 weeks. The beta is 0.09, so NSE:HCG's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -23.27% |
| 50-Day Moving Average | 639.32 |
| 200-Day Moving Average | 623.74 |
| Relative Strength Index (RSI) | 40.43 |
| Average Volume (20 Days) | 115,009 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCG had revenue of INR 27.12 billion and earned 112.95 million in profits. Earnings per share was 0.77.
| Revenue | 27.12B |
| Gross Profit | 14.28B |
| Operating Income | 2.35B |
| Pretax Income | 386.90M |
| Net Income | 112.95M |
| EBITDA | 4.13B |
| EBIT | 2.35B |
| Earnings Per Share (EPS) | 0.77 |
Balance Sheet
The company has 1.27 billion in cash and 16.09 billion in debt, with a net cash position of -14.82 billion or -99.26 per share.
| Cash & Cash Equivalents | 1.27B |
| Total Debt | 16.09B |
| Net Cash | -14.82B |
| Net Cash Per Share | -99.26 |
| Equity (Book Value) | 14.34B |
| Book Value Per Share | 90.09 |
| Working Capital | -758.60M |
Cash Flow
In the last 12 months, operating cash flow was 2.94 billion and capital expenditures -2.64 billion, giving a free cash flow of 298.58 million.
| Operating Cash Flow | 2.94B |
| Capital Expenditures | -2.64B |
| Depreciation & Amortization | 1.78B |
| Net Borrowing | -1.71B |
| Free Cash Flow | 298.58M |
| FCF Per Share | 2.00 |
Margins
Gross margin is 52.65%, with operating and profit margins of 8.66% and 0.42%.
| Gross Margin | 52.65% |
| Operating Margin | 8.66% |
| Pretax Margin | 1.43% |
| Profit Margin | 0.42% |
| EBITDA Margin | 15.23% |
| EBIT Margin | 8.66% |
| FCF Margin | 1.10% |
Dividends & Yields
NSE:HCG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.40% |
| Shareholder Yield | -3.40% |
| Earnings Yield | 0.13% |
| FCF Yield | 0.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:HCG is 796.89, which is 39.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 796.89 |
| Price Target Difference | 39.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 14.98% |
| EPS Growth Forecast (3Y) | 88.22% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |